Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 12, 2026 · Leadership change · Item 3.02 · Item 3.03 · +2 more
Avalo Therapeutics, Inc.
16
Leadership change
Jun 12, 2026
| ItemItem | Disclosure |
|---|---|
| Item 3.02 | Item 3.02 |
| Item 3.03 | Item 3.03 |
| Item 5.02 | Director or executive officer departure or appointment |
| Item 5.03 | Amended articles of incorporation or bylaws |
| Item 9.01 | Financial statements and exhibits |
Avalo Therapeutics, Inc. filed this to disclose a change in directors or executive officers appointments, departures, or role changes that can signal a strategic shift.
) 1500 Liberty Ridge Drive, Suite 321 , Wayne , Pennsylvania 19087 (Address of principal executive offices) (Zip Code) Registrant’s Telephone Number, Including Area Code: ( 410 ) 522-8707 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230. 425) ☐ Soliciting material pursuant to Rule14a-12 under the Exchange Act (17…
This filing reports Item 5.02 (director or executive officer departure or appointment). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Avalo Therapeutics, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
